Concurrent BRAF/MEK Inhibitors in BRAF V600–Mutant High-Grade Primary Brain Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concurrent BRAF/MEK Inhibitors in BRAF V600–Mutant High-Grade Primary Brain Tumors

Published:2018-04 Issue:4 Volume:16 Page:343-347
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:en
Short-container-title:J Natl Compr Canc Netw

Author:

Schreck Karisa C.,Guajardo Andrew,Lin Doris D.M.,Eberhart Charles G.,Grossman Stuart A.

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation;Acta Neuropathologica Communications;2024-08-06

2. Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms;Frontiers in Oncology;2023-10-18

3. Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing;OMICS: A Journal of Integrative Biology;2023-09-01

4. BRAF Mutations in CNS Tumors—Prognostic Markers and Therapeutic Targets;CNS Drugs;2023-06-02

5. Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study;Clinical Oncology;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP